Strategic Review Committee
The members below reviewed applications for some or all of the following programs:
- Biosciences Research Infrastructure Fund (BRIF 1)
- Clinical Trials Fund (CTF)
- Canada Biomedical Research Fund (CBRF) Stage 1
Chair
Karimah Es-Sabar
Chief executive officer and general partner
Quark Venture LP
Canada
Members
Kristin Baetz
Dean, Faculty of Science
University of Calgary
Canada
Jane M. Barratt
Secretary general, International Federation on Ageing
Canada
Luis Barreto
President
Dr. Luis Barreto & Associates
Canada
Imogen Coe
Professor, Department of Chemistry and Biology, Faculty of Science
Toronto Metropolitan University
Canada
David Dolphin
Original vice-president, Technology Development
Quadra Logic Technologies
Professor emeritus
The University of British Columbia
Canada
Elizabeth Eisenhauer
Professor emerita
Department of Oncology, School of Medicine, Faculty of Health Sciences
Queen’s University
Canada
Syra Madad
Fellow, Harvard Belfer Center for Science and International Affairs, and senior director, System-wide Special Pathogens Program
NYC Health + Hospitals
United States
Kibret Mequanint
Professor, Department of Chemical and Biochemical Engineering
Professor, School of Biomedical Engineering
Western University
Canada
Peter A. Newman
Professor, Factor-Inwentash Faculty of Social Work
Faculty affiliate, Joint Centre for Bioethics, Dalla Lana School of Public Health
University of Toronto
Canada
Ishwar K. Puri
Senior vice-president, Research & Innovation, and professor
University of Southern California
United States
Refer inquiries to the relevant funding organization. Do not contact Strategic Review Committee (SRC) members directly. SRC members will not share any information regarding the competition, review process or results.
- Date modified: